In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Peter Ueda
Speaker
Peter Ueda
Peter Ueda Peter Ueda

Karolinska Institute, Stockholm (Sweden)

Specialities : Pharmacology and Pharmacotherapy , Public Health and Health Economics, Risk Factors and Prevention

MD/PhD, Karolinska Institutet (2007-2014); Post-doctoral researcher, Harvard University (2015-2017); Intern physician, South Hospital, Stockholm & Post-doctoral researcher, Karolinska Institutet (2018); Current research focus include effectiveness and safety of novel glucose-lowering drugs and dual antiplatelet therapy after coronary stenting.

3 presentations from this speaker

Cohort Study of Serious Adverse Events with Sodium-Glucose Cotransporter 2 Inhibitors

Event : ESC Congress 2018

  • Session : Late Breaking Pharmacological Science
  • Speaker : P Ueda (Stockholm,SE)

External validation of the DAPT score in nationwide real-world data: ischemic and bleeding events following coronary stent implantation

Event : ESC Congress 2018

  • Session : The value of risk scores for assessment in acute coronary syndrome
  • Speaker : P Ueda (Stockholm,SE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are